The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid Multiplex Assays Market Research Report 2024
Synopsis
Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
The global Nucleic Acid Multiplex Assays market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nucleic Acid Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nucleic Acid Multiplex Assays include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Multiplex Assays.
Report Scope
The Nucleic Acid Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
The global Nucleic Acid Multiplex Assays market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nucleic Acid Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nucleic Acid Multiplex Assays include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Multiplex Assays.
Report Scope
The Nucleic Acid Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assays Market Perspective (2019-2030)
2.2 Nucleic Acid Multiplex Assays Growth Trends by Region
2.2.1 Global Nucleic Acid Multiplex Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid Multiplex Assays Historic Market Size by Region (2019-2024)
2.2.3 Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2025-2030)
2.3 Nucleic Acid Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid Multiplex Assays Industry Trends
2.3.2 Nucleic Acid Multiplex Assays Market Drivers
2.3.3 Nucleic Acid Multiplex Assays Market Challenges
2.3.4 Nucleic Acid Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid Multiplex Assays Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Multiplex Assays Revenue
3.4 Global Nucleic Acid Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assays Revenue in 2023
3.5 Nucleic Acid Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Multiplex Assays Product Solution and Service
3.7 Date of Enter into Nucleic Acid Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Type (2019-2024)
4.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2025-2030)
5 Nucleic Acid Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Application (2019-2024)
5.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Multiplex Assays Market Size (2019-2030)
6.2 North America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid Multiplex Assays Market Size by Country (2019-2024)
6.4 North America Nucleic Acid Multiplex Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assays Market Size (2019-2030)
7.2 Europe Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid Multiplex Assays Market Size by Country (2019-2024)
7.4 Europe Nucleic Acid Multiplex Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assays Market Size (2019-2030)
9.2 Latin America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2019-2024)
9.4 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Nucleic Acid Multiplex Assays Introduction
11.1.4 Abcam Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Becton
11.2.1 Becton Company Detail
11.2.2 Becton Business Overview
11.2.3 Becton Nucleic Acid Multiplex Assays Introduction
11.2.4 Becton Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.2.5 Becton Recent Development
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Detail
11.3.2 Dickinson and Company Business Overview
11.3.3 Dickinson and Company Nucleic Acid Multiplex Assays Introduction
11.3.4 Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.3.5 Dickinson and Company Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Nucleic Acid Multiplex Assays Introduction
11.4.4 Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.4.5 Merck KGaA Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Nucleic Acid Multiplex Assays Introduction
11.5.4 Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.5.5 Agilent Technologies Recent Development
11.6 Bio-Techne
11.6.1 Bio-Techne Company Detail
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Nucleic Acid Multiplex Assays Introduction
11.6.4 Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.6.5 Bio-Techne Recent Development
11.7 Shimadzu Biotech
11.7.1 Shimadzu Biotech Company Detail
11.7.2 Shimadzu Biotech Business Overview
11.7.3 Shimadzu Biotech Nucleic Acid Multiplex Assays Introduction
11.7.4 Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.7.5 Shimadzu Biotech Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Nucleic Acid Multiplex Assays Introduction
11.8.4 Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Multiplex Assays Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Multiplex Assays Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.10.5 Qiagen Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Detail
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Nucleic Acid Multiplex Assays Introduction
11.11.4 Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2019-2024)
11.11.5 Luminex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assays Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Nucleic Acid Multiplex Assays Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Nucleic Acid Multiplex Assays Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assays Market Share by Region (2019-2024)
Table 9. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assays Market Share by Region (2025-2030)
Table 11. Nucleic Acid Multiplex Assays Market Trends
Table 12. Nucleic Acid Multiplex Assays Market Drivers
Table 13. Nucleic Acid Multiplex Assays Market Challenges
Table 14. Nucleic Acid Multiplex Assays Market Restraints
Table 15. Global Nucleic Acid Multiplex Assays Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assays Market Share by Players (2019-2024)
Table 17. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2023)
Table 18. Ranking of Global Top Nucleic Acid Multiplex Assays Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assays Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nucleic Acid Multiplex Assays Product Solution and Service
Table 22. Date of Enter into Nucleic Acid Multiplex Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assays Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2019-2024)
Table 26. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2025-2030)
Table 28. Global Nucleic Acid Multiplex Assays Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2019-2024)
Table 30. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2025-2030)
Table 32. North America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Nucleic Acid Multiplex Assays Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Nucleic Acid Multiplex Assays Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Nucleic Acid Multiplex Assays Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Nucleic Acid Multiplex Assays Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Nucleic Acid Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abcam Company Detail
Table 48. Abcam Business Overview
Table 49. Abcam Nucleic Acid Multiplex Assays Product
Table 50. Abcam Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Becton Company Detail
Table 53. Becton Business Overview
Table 54. Becton Nucleic Acid Multiplex Assays Product
Table 55. Becton Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 56. Becton Recent Development
Table 57. Dickinson and Company Company Detail
Table 58. Dickinson and Company Business Overview
Table 59. Dickinson and Company Nucleic Acid Multiplex Assays Product
Table 60. Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 61. Dickinson and Company Recent Development
Table 62. Merck KGaA Company Detail
Table 63. Merck KGaA Business Overview
Table 64. Merck KGaA Nucleic Acid Multiplex Assays Product
Table 65. Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 66. Merck KGaA Recent Development
Table 67. Agilent Technologies Company Detail
Table 68. Agilent Technologies Business Overview
Table 69. Agilent Technologies Nucleic Acid Multiplex Assays Product
Table 70. Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 71. Agilent Technologies Recent Development
Table 72. Bio-Techne Company Detail
Table 73. Bio-Techne Business Overview
Table 74. Bio-Techne Nucleic Acid Multiplex Assays Product
Table 75. Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 76. Bio-Techne Recent Development
Table 77. Shimadzu Biotech Company Detail
Table 78. Shimadzu Biotech Business Overview
Table 79. Shimadzu Biotech Nucleic Acid Multiplex Assays Product
Table 80. Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 81. Shimadzu Biotech Recent Development
Table 82. Thermo Fisher Scientific Company Detail
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Nucleic Acid Multiplex Assays Product
Table 85. Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Bio-Rad Laboratories Company Detail
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Nucleic Acid Multiplex Assays Product
Table 90. Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Development
Table 92. Qiagen Company Detail
Table 93. Qiagen Business Overview
Table 94. Qiagen Nucleic Acid Multiplex Assays Product
Table 95. Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Luminex Corporation Company Detail
Table 98. Luminex Corporation Business Overview
Table 99. Luminex Corporation Nucleic Acid Multiplex Assays Product
Table 100. Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2019-2024) & (US$ Million)
Table 101. Luminex Corporation Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Multiplex Assays Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nucleic Acid Multiplex Assays Market Share by Type: 2023 VS 2030
Figure 3. Planar Nucleic Acid Assays Features
Figure 4. Bead-Based Nucleic Acid Assays Features
Figure 5. Other Nucleic Acid Assays Features
Figure 6. Global Nucleic Acid Multiplex Assays Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nucleic Acid Multiplex Assays Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Hospitals & Research Institutes Case Studies
Figure 10. Reference Laboratories Case Studies
Figure 11. Other End Users Case Studies
Figure 12. Nucleic Acid Multiplex Assays Report Years Considered
Figure 13. Global Nucleic Acid Multiplex Assays Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Nucleic Acid Multiplex Assays Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Nucleic Acid Multiplex Assays Market Share by Region: 2023 VS 2030
Figure 16. Global Nucleic Acid Multiplex Assays Market Share by Players in 2023
Figure 17. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assays Revenue in 2023
Figure 19. North America Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Nucleic Acid Multiplex Assays Market Share by Country (2019-2030)
Figure 21. United States Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nucleic Acid Multiplex Assays Market Share by Country (2019-2030)
Figure 25. Germany Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nucleic Acid Multiplex Assays Market Share by Region (2019-2030)
Figure 33. China Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nucleic Acid Multiplex Assays Market Share by Country (2019-2030)
Figure 41. Mexico Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Share by Country (2019-2030)
Figure 45. Turkey Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Nucleic Acid Multiplex Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abcam Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 48. Becton Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 49. Dickinson and Company Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 50. Merck KGaA Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 52. Bio-Techne Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 53. Shimadzu Biotech Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 56. Qiagen Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 57. Luminex Corporation Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
